Aaron Sato | Chief Scientific Officer of Twist Biopharma
Twist Bioscience

Aaron Sato, Chief Scientific Officer of Twist Biopharma, Twist Bioscience

Aaron is CSO of the Biopharma Vertical at Twist Bioscience.  Prior to Twist, he served as Chief Scientific Officer of LakePharma, leading the California Antibody Center, which discovers novel antibody therapeutics for its clients. He also oversaw all discovery research functions both as Vice President of Protein Sciences at Surrozen, and previously, as Vice President of Research at Sutro Biopharma, Inc. He also held director level positions at both Oncomed and Dyax Corp.

Appearances:



Festival of Biologics Day 1 @ 14:20

Twist Biopharma: Writing the Future of Biologics to Discover and Optimize Single Domain Antibodies

Utilizing its proprietary DNA technology to write synthetic libraries, Twist Biopharma provides end-to-end antibody discovery and optimization solutions including a panel of highly diverse synthetic naïve single domain antibody phage display libraries. In this presentation, Aaron will give an overview of these libraries and present several case studies.
last published: 17/Sep/21 16:05 GMT
last published: 17/Sep/21 16:05 GMT
last published: 17/Sep/21 16:05 GMT
last published: 17/Sep/21 16:05 GMT

back to speakers